CB Therapeutics has developed an innovative and proprietary cellular agriculture platform to efficiently research, discover, develop and produce therapeutic compounds to advance Neuroscience.


Therapeutic compounds produced directly from yeast – made from simple sugars.


Delivering greater purity, consistency and efficiency than from Mother Nature.


Advancing science and mental healthcare through controlled clinical trials.

Therapeutic Compounds

Utilizing our proprietary synthetic genomics and bio-engineering platform.

We are bringing promising cannabinoid and tryptamine therapeutics to the clinic and to the market to treat depression, PTSD, opioid addiction, alcoholism, anxiety, pain and other mental healthcare and social challenges.

We are advancing our proprietary production platform, intellectual property portfolio and the science of Cellular Agriculture to build on its promise to meet the health and wellness needs of mankind.